STXI ETF Analysis

Bu sayfa İngilizce aslından yapay zekâ ile çevrildi; İngilizce sürüm esastır. İngilizce sürümü oku

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir.

Kısa Cevap

In the stored portfolio snapshot dated Mar 15, 2026, the largest listed holding is ASML Holding NV (ASML.AS) at 2.94%.

STXI ETF — Price, Holdings & Analysis

ETF Genel Bakış

STXI aims to replicate the performance of an index comprised of a small selection of global stocks. The ETF achieves this by investing in the constituent companies of the underlying index, weighting them according to their index representation. STXI offers a concentrated approach to global equities, potentially leading to higher volatility compared to more diversified ETFs. The fund's top holdings include ASML Holding NV (2.94%), Novartis AG Registered Shares (1.77%), and Roche Holding AG (1.77%). Other significant allocations include HSBC Holdings PLC (1.71%) and AstraZeneca PLC (1.67%). This concentrated portfolio may appeal to investors seeking targeted exposure to specific global companies rather than broad market diversification. STXI's strategy is suited for investors with a higher risk tolerance seeking concentrated exposure.

Risk Metrikleri

STXI's presents a significant concentration risk. A downturn in any of its top holdings, such as ASML Holding NV, Novartis AG, or Roche Holding AG, could disproportionately impact the ETF's performance. The ETF's three-year beta of 0.00 suggests it has historically exhibited very low volatility relative to the market. However, this may not hold true in all market conditions, especially given the concentrated nature of its holdings. Investors should carefully consider their risk tolerance and investment objectives before investing in STXI, acknowledging the potential for amplified volatility due to its concentrated nature. Past performance does not guarantee future results.

Beta: 0.00

STXI hangi varlıkları tutuyor?

Varlık	Ağırlık
ASML Holding NV (ASML.AS)	2.94%
Novartis AG Registered Shares (NOVN.SW)	1.77%
Roche Holding AG (ROG.SW)	1.77%
HSBC Holdings PLC (HSBA.L)	1.71%
AstraZeneca PLC (AZN.L)	1.67%
Nestle SA (NESN.SW)	1.49%
Toyota Motor Corp (7203.T)	1.33%
Shell PLC (SHEL.L)	1.26%
Siemens AG (SIE.DE)	1.20%
Royal Bank of Canada (RY)	1.18%

Varlıklar ve ağırlıklar 15 Mar 2026 itibarıyla. Bu fon verileri 45 günden eski; güncel varlıkları ihraççıdan doğrulayın.

Temettü Verimi

0.00%

Sorular & Cevaplar

What is STXI and what does it track?

STXI is an exchange-traded fund (ETF) designed to track the performance of a specific index composed of a small selection of global stocks.

The ETF provides investors with a way to gain exposure to these companies through a single investment vehicle. As of 2026-03-15, with top allocations including ASML Holding NV, Novartis AG, and Roche Holding AG.

What are the top holdings in STXI?

As of 2026-03-15, the top five holdings in STXI are: 1) ASML Holding NV (ASML.AS) at 2.94%, 2) Novartis AG Registered Shares (NOVN.SW) at 1.77%, 3) Roche Holding AG (ROG.SW) at 1.77%, 4) HSBC Holdings PLC (HSBA.L) at 1.71%, and…

5) AstraZeneca PLC (AZN.L) at 1.67%.

Is STXI a good long-term investment?

Whether STXI is a suitable long-term investment depends on an investor's individual circumstances, risk tolerance, and investment objectives. The ETF's may lead to higher volatility compared to more diversified options.

As of 2026-03-15, STXI has a dividend yield of 0.00% and a three-year beta of 0.00. Investors should carefully consider these factors and conduct thorough research before making any investment decisions. Past performance does not guarantee future results.

How does STXI compare to similar ETFs?

However, STXI's defining characteristic is its highly. Many similar ETFs tracking global equities will hold a much larger number of companies, providing greater diversification.

Investors should compare STXI's expense ratio (not available in provided data), AUM, and investment strategy to those of other global equity ETFs to determine which fund best aligns with their needs. The level of concentration is a key differentiator.

Does STXI pay dividends?

As of 2026-03-15, STXI exhibits a dividend yield of 0.00%. This indicates that the ETF is not currently distributing any dividend income to its shareholders. Investors seeking dividend income may want to consider alternative ETFs with a higher dividend yield.

However, dividend yield is only one factor to consider when evaluating an ETF's overall suitability.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Bu sayfayı makine yazdı, sayfa sayfa insan denetiminden geçmedi. Editoryal denetim sistemiktir: kurallar ve kaynaklar denetlenir, tek tek sayfalar denetlenmez.